Patient Lifestyle

Technological gains and courage to try experimental therapies inspire a veteran MD

Key late-breaking clinical trials from the American College of Cardiology’s 58th annual scientific session

GlaxoSmithKline is introducing Tykerb, a dual kinase inhibitor that inhibits breast cancer cell growth.

First major study shows no cure rate after one year of treatment but researchers blame trial design

Researcher urges primary-care physicians to screen all obese women for condition

Researcher says excess protein can activate environmental toxins and promote proliferation of precancerous cells